Newsy: Black healthcare workers aim to build trust in COVID-19 vaccine
Family medicine physician speaks out about fears and science behind COVID-19
A Pew poll found just 42% of Black Americans are willing to get vaccinated, despite 71% knowing someone who died or has been hospitalized from COVID. The concerns about public confidence in the COVID vaccines, especially within the Black community, has prompted many in the medical community to speak directly to those worries.
Louito Edje, MD, associate dean for graduate medical education at the UC College of Medicine and UC Medical Center, spoke with Newsy for a televised segment about the history that leads to hesitation for some in the Black community when it comes to vaccinations.
The Tuskegee experiment that left Black men untreated for syphilis and the brutal gynecological studies on enslaved Black women are only some of the examples.
“So there's history, and it's very justified,” says Edje, also a UC Health family medicine physician. “I think the biggest impact that we will have is actually having those of us who have the vaccine, who live in communities with other people, see that we're doing very well."
Edje advocated for science right from the start. After her stepmother died from COVID, she volunteered for the Moderna vaccine clinical trial. She wanted to lead by example.
Listen to the full interview with Louito Edje, MD, and others on Newsy.
Other media also interviewed Edje for stories on this topic.
Learn more about Edje’s thoughts on COVID-19 online.
Featured image of Louito Edje, MD, in the UC College of Medicine Simulation Center taken by Colleen Kelley/University of Cincinnati.
Related Stories
The Last Show with David Cooper discusses AI in education with UC’s Joshua Lambert
April 12, 2026
The Last Show with David Cooper, a global news podcast, featured Joshua Lambert, PhD, a professor and biostatistician in UC College of Nursing to discuss his latest research on using artificial intelligence for student advising.
UC enrolls first patients in clinical trial for prosthetic joint infections
April 10, 2026
The University of Cincinnati has enrolled the first patients in Peptilogics’ RETAIN clinical trial, testing an investigational drug for prosthetic joint infections after total knee replacement to reduce repeat surgeries and infection recurrence.
Long before machine guns, ancient Romans used this rapid-fire weapon
April 9, 2026
Smithsonian highlights research by UC Classics Professor Steven Ellis, who supervised archaeological work in the Porta Stabia neighborhood of Pompeii.